{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:40:35Z","timestamp":1791906035219,"version":"4.3.4"},"reference-count":152,"publisher":"Informa UK Limited","issue":"9","funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","award":["408778\/2022\u20139, 307946\/2022\u20133, 444735\/2023\u20132"],"award-info":[{"award-number":["408778\/2022\u20139, 307946\/2022\u20133, 444735\/2023\u20132"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Foundation to Support the Development of Education, Science, and Technology of the State of Mato Grosso do Sul","award":["76\/2023"],"award-info":[{"award-number":["76\/2023"]}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education Personnel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020983","name":"Federal University of Grande Dourados","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020983","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/13543776.2025.2545784","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T05:40:32Z","timestamp":1754718032000},"page":"983-999","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["The potential of bacteriophages in treating multidrug-resistant ESKAPE pathogen infections"],"prefix":"10.1080","volume":"35","author":[{"given":"Izadora Dillis","family":"Faccin","sequence":"first","affiliation":[{"name":"Laboratory of Health Sciences Research (LPCS)","place":["Dourados, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-9109","authenticated-orcid":false,"given":"Gleyce","family":"Hellen de Almeida de Souza","sequence":"additional","affiliation":[{"name":"Laboratory of Health Sciences Research (LPCS)","place":["Dourados, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Carlos Pael","family":"Vicente","sequence":"additional","affiliation":[{"name":"Laboratory of Health Sciences Research (LPCS)","place":["Dourados, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"da Silva Damaceno","sequence":"additional","affiliation":[{"name":"Laboratory of Health Sciences Research (LPCS)","place":["Dourados, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Vit\u00f3ria de Oliveira Perez","sequence":"additional","affiliation":[{"name":"Laboratory of Health Sciences Research (LPCS)","place":["Dourados, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willames","family":"Martins","sequence":"additional","affiliation":[{"name":"University of Oxford","place":["Oxford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Gales","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo (UNIFESP), Division of Infectious Diseases","place":["S\u00e3o Paulo, Brazil"]},{"name":"Universidade Federal de S\u00e3o Paulo (UNIFESP)","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2367-0915","authenticated-orcid":false,"given":"Simone","family":"Simionatto","sequence":"additional","affiliation":[{"name":"Laboratory of Health Sciences Research (LPCS)","place":["Dourados, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10101310"},{"key":"e_1_3_4_4_1","unstructured":"World Health Organization. WHO bacterial priority pathogens list 2024: bacterial pathogens of public health importance to guide research development and strategies to prevent and control antimicrobial resistance [Internet]. 2024 [cited 2024 Aug 9]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240093461"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14010034"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2021.103863"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.01.014"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.09.004"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2015.12.011"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jobm.201800412"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012435"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010325"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae117"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fux022"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2018.1447291"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.890955"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64145-7"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00411-22"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S215084"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa389"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku552"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsre.2003.08.001"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.649-659.2001"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2388-7"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15020420"},{"key":"e_1_3_4_26_1","unstructured":"Cohen R Merril G. Adaptive phage therapeutics Inc assignee. System and method to select phage therapy based on time and location. WO patent WO 2021\/138218 A1. 2021 May 16."},{"key":"e_1_3_4_27_1","unstructured":"Cohen R. Inventor; adaptive phage therapeutics Inc assignee. Computer implemented method and system for optimizing phage selection. WO patent WO\u202f2023\/049699\u202fA1. 2023 Apr 27."},{"key":"e_1_3_4_28_1","unstructured":"Cohen R Merril G BarretoSanz M et al. Inventors; adaptive phage therapeutics Inc assignee. Machine learning system for interpreting host phage response. CA patent CA\u202f3159797\u202fA1. 2021 Jul 8."},{"key":"e_1_3_4_29_1","unstructured":"Merril C Merril G. Inventors; adaptive phage therapeutics Inc assignee. Phage dispensing system. WO patent WO\u202f2019\/118310\u202fA1. 2019 Nov 14."},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-56154-7_33"},{"key":"e_1_3_4_31_1","first-page":"1","volume-title":"2019 IEEE Latin American Conference on Computational Intelligence (LA-CCI) [Internet]","author":"L\u00f3pez JF","unstructured":"L\u00f3pez JF, Sotelo JAL, Leite D, et al. Applying one-class learning algorithms to predict phage-bacteria interactions. In: 2019 IEEE Latin American Conference on Computational Intelligence (LA-CCI) [Internet]; Guayaquil, Ecuador. [cited 2024 Jul 13]. p. 1\u20136. Available from: https:\/\/ieeexplore.ieee.org\/document\/9037032"},{"key":"e_1_3_4_32_1","unstructured":"Merril C. Inventor; adaptive phage therapeutics Inc assignee. Methods of determining the sensitivity profile of a bacterial strain to a therapeutic composition. WO patent WO\u202f2019\/050902\u202fA1. 2019 Mar 14."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14020342"},{"key":"e_1_3_4_34_1","unstructured":"Cohen R Merril G BarretoSanz M. Inventors; adaptive phage therapeutics Inc assignee. Phage dispensing system. WO patent WO\u202f2023\/039575\u202fA1. 2023 Mar 16."},{"key":"e_1_3_4_35_1","unstructured":"Baeza CPP Aracena FAR Guerra AAO et al. Inventors; Phagelab Chile Spa assignee. Methods and systems for designing phage cocktails. WO patent WO\u202f2023\/242621\u202fA1. 2023 Dec 21."},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14071490"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0089-y"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.577634"},{"key":"e_1_3_4_39_1","unstructured":"Corsini L Visram ZC Mutti M et al. Inventors; Biontech R&D (Austria) GmbH assignee. New mosaic bacteriophages and uses thereof. WO patent WO\u202f2022\/013318\u202fA1. 2022 Jan 20."},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00476"},{"key":"e_1_3_4_41_1","unstructured":"Fackler J. Inventor; adaptive phage therapeutics Inc. assignee. Assay for matching phage to bacteria. WO patent WO\u202f2023\/122608\u202fA1. 2023 Nov 2."},{"key":"e_1_3_4_42_1","unstructured":"Xiujuan H Jialiang C Qin L. Inventors; Hong Kong microbiota innovation Centre Ltd assignee. Treatments for bacterial infections. CN patent cn\u202f115038799\u202fa. 2022 Jun 14."},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.363"},{"key":"e_1_3_4_44_1","unstructured":"Deng L Huang H Xue J. Inventors; Helmholtz Zentrum M\u00fcnchen assignee. Bactericidal phage vectors. WO patent WO\u202f2021\/048257\u202fA1. 2021 Mar 18."},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuv048"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac258"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81063-4"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1039\/c5ib00267b"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00069-15"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2021.12.003"},{"key":"e_1_3_4_51_1","unstructured":"Collins JJ Lu TK. inventors; Massachusetts Institute of Technology assignee. Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof. US patent US\u202f2010\/0322903\u202fA1. Boston University; 2010 Dec 23."},{"key":"e_1_3_4_52_1","article-title":"Phico therapeutics limited, assignee. Bacteriophages with multiple hosts and different tail fibers","author":"Fairhead H","year":"2017","unstructured":"Fairhead H, Wilkinson A, Pitts K, et al., inventors; Phico therapeutics limited, assignee. Bacteriophages with multiple hosts and different tail fibers. JP Patent JP\u202f2017\/532036\u202fa. 2017 Sep 28.","journal-title":"JP Patent JP\u202f2017\/532036\u202fa"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-765X.2003.01400.x"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3817-3822.2004"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0437-z"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-021-00480-z"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2008.09.012"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2010.04.002"},{"key":"e_1_3_4_59_1","unstructured":"Donovan DM Inventor USDA. Department of agriculture assignee. Triple acting antimicrobials that are refractory to resistance development. AU patent AU\u202f2009\/273845\u202fB2. 2016 Jun 29."},{"key":"e_1_3_4_60_1","unstructured":"Donovan DM Abaev IV. Inventors; USDA state research center for applied microbiology and biotechnology assignee. Staphylococcal phage2638a endolysin amidase domain is lytic for Staphylococcus aureus. WO patent WO\u202f2013\/188203\u202fA1. 2013 Nov 28."},{"key":"e_1_3_4_61_1","unstructured":"Donovan DM Mao J Inventors USDA. Department of agriculture assignee. Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin. US patent US\u202f8 790 639\u202fB2. 2014 Jul 29."},{"key":"e_1_3_4_62_1","article-title":"Lysk endolysin is synergistic with lysostaphin against MRSA","author":"Donovan DM","year":"2010","unstructured":"Donovan DM, Mao J. inventors; USDA, Secretary of Agriculture. assignee. Lysk endolysin is synergistic with lysostaphin against MRSA. WO Patent WO\u202f2010\/036408\u202fA3. 2010 Aug 14.","journal-title":"WO Patent WO\u202f2010\/036408\u202fA3"},{"key":"e_1_3_4_63_1","unstructured":"Donovan DM Rodriguez RL Martinez FB et al. Inventors; USDA department of agriculture assignee. Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_saus-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions deletions and synergy with LysH5. US patent US\u202f2015\/247138\u202fA1. 2015 Aug 20."},{"key":"e_1_3_4_64_1","unstructured":"Schuch R Nowinski RC Wittekind M et al. Inventors; Contrafect corporation assignee. Bacteriophage lysin and antibiotic combinations against gram positive bacteria. US patent US\u202f2021\/0008175\u202fA1. 2021 Jan 07."},{"key":"e_1_3_4_65_1","unstructured":"Donovan DM Abaev IV Schmelcher M. Inventors; USDA department of agriculture assignee. Staphylococcus haemolyticus prophage PhiSH2 endolysin is lytic for Staphylococcus aureus. US patent US\u202f2014\/0065127\u202fA1. 2014 Feb 6."},{"key":"e_1_3_4_66_1","unstructured":"Goh BC. Inventor; Phico therapeutics Ltd. assignee. Engineered chimeric antimicrobial agents against gram-positive bacteria. WO patent WO\u202f2022\/104171\u202fA8. 2022 Jun 16."},{"key":"e_1_3_4_67_1","unstructured":"Donovan DM Inventor USDA. Secretary of Agriculture assignee. Specific lysis of Staphylococcus pathogens by bacteriophage phi11 endolysin. US patent US\u202f2011\/0318328\u202fA1. 2011 Jul 27."},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.2005.01781.x"},{"key":"e_1_3_4_69_1","unstructured":"Schmelcher M R\u00f6hrig CA Huemer M et al. Inventors; Micreos pharmaceuticals assignee. A chimeric endolysin polypeptide. WO patent WO\u202f2024\/133850\u202fA1. 2024 Jun 27."},{"key":"e_1_3_4_70_1","unstructured":"Fischetti VA Schmitz J Gilmer D et al. inventors; Streptococcus bacteriophage lysins for detection and treatment of gram-positive bacteria. CN patent cn\u202f103857410\u202fa. Rockefeller University assignee. 2014 Jun 11."},{"key":"e_1_3_4_71_1","unstructured":"Garcia MAC Pimentel MMV Jos\u00e9 SSCJ et al. Inventors; Technophage Bluepharma SA assignees. Enterococcal phage peptides and methods of use thereof. WO patent WO\u202f2011\/065854\u202fA1. 2011 Jun 3."},{"key":"e_1_3_4_72_1","unstructured":"Donovan DM. Inventor; United States department of agriculture (USDA) assignee. Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin. US patent US\u202f2011\/0318328\u202fA1. 2011 Dec 29."},{"key":"e_1_3_4_73_1","unstructured":"Fischetti V Raz A Andersson M et al. Inventors; the Rockefeller University assignee. Recombinant lysins. WO patent WO\u202f2019\/226949\u202fA1. 2019 Nov 28."},{"key":"e_1_3_4_74_1","unstructured":"Kim J Jin J Kim S et al. Inventors; Kyungpook National University industry-Academic cooperation Foundation assignee. Use of novel recombinant enzyme LysSAP26 killing pathogenic bacteria. KR patent KR\u202f102131692\u202fB1. 2020 Jul 8."},{"key":"e_1_3_4_75_1","unstructured":"Schuch R. Inventor; ContraFect corporation assignee. Cytolysin and its derivatives that have bactericidal activity against Pseudomonas aeruginosa in the presence of human serum. JP patent jp\u202f2022526978\u202fa. 2022 May 27."},{"key":"e_1_3_4_76_1","unstructured":"Yang X Lin Z Fu Y et al. Inventors; Guangzhou novo synthetic biotechnology Co Ltd assignee. Endolysin Lys009 engineering modification and application thereof. CN patent cn\u202f117660413\u202fa. 2024 Mar 8."},{"key":"e_1_3_4_77_1","unstructured":"Schuch R. Inventor; ContraFect Corp assignee. Enhancement of blood components with antibacterial activity of lysate proteins method and use thereof. CN patent cn\u202f116603056\u202fa. 2023 Aug 18."},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04641-14"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00024-19"},{"key":"e_1_3_4_80_1","unstructured":"Schuch R. Inventor; Contrafect corporation assignee. Amurins lysins and lysin\u2013antimicrobial peptide (AMP) constructs active against gram-negative bacteria. WO patent WO\u202f2022\/204280\u202fA1. 2022 Nov 3."},{"key":"e_1_3_4_81_1","unstructured":"Antonova NP Vasina DV Gintsburg AL et al. Inventors; Gamaleya research center for epidemiology and microbiology assignee. Antibacterial composition and use of protein as antimicrobial agent directed against Pseudomonas aeruginosa Klebsiella pneumoniae Escherichia coli salmonella typhi and Staphylococcus haemolyticus. RU patent RU2730613C1. 2020 Aug 24."},{"key":"e_1_3_4_82_1","unstructured":"Cao H Wu H Li G et al. Inventors; Shanghai Hi-Tech United bio Technological research & development Co Ltd assignee. Phage lyase recombinant polypeptide En6\u20131 and encoding gene thereof. CN patent CN117625658A. 2024 Mar 1."},{"key":"e_1_3_4_83_1","unstructured":"Vander EN Briers Y Meyer E et al. Inventors; Universiteit gent katholieke Universiteit Leuven assignee. Chimeric endolysins with activity against streptococci and staphylococci. WO patent WO 2024\/200687. 2024 Oct 3 p. A1."},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02723-20"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.05261-22"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab466.1648"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy210.1173"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae043"},{"key":"e_1_3_4_89_1","unstructured":"Corsini L Kluj R Sch\u00f6tta A et al. Inventors; BioNTech SE assignee. Peptidoglycan hydrolases with bactericidal activity. WO patent WO 2024\/184533. 2024 Sep 12 p. A1."},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00022"},{"key":"e_1_3_4_91_1","unstructured":"Duong TTH Iredell J Huang H et al. Inventors; the University of Sydney the Westmead Institute for medical research Western Sydney local Health district assigneePhage-drug conjugate. WO patentWO2023\/092196 A1. 2023 Jun 1."},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00169-06"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.03.003"},{"key":"e_1_3_4_94_1","unstructured":"Mande SS Anand S Sampath PA. Inventors; Tata consultancy services Ltd assignee. System and method for combating infections due to antibiotic induced pathogens. US patent US20220233637A1. 2022 Jul 28."},{"key":"e_1_3_4_95_1","unstructured":"Szabolcs S. Inventor; snipr biome ApS assignee. Methods uses & compositions. WO patent WO2020152369A1. 2020 Jul 30."},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02083-21"},{"key":"e_1_3_4_97_1","unstructured":"Haaber JK Szabolcs S. Inventors; SNIPR biome ApS assignee phage and transduction particles. CA patent CA3083668A1. 2019 Jun 6."},{"key":"e_1_3_4_98_1","unstructured":"Junghans SF. Inventor; Phatec GmbH assignee. Hydroxyethylcellulose gel compositions comprising bacteriophages. EP patent EP\u202f4302787\u202fA1. 2024 Jan 10."},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16070942"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02620-w"},{"key":"e_1_3_4_101_1","unstructured":"Vronka J. inventor; A preparation for the supportive skin treatment in case of atopic dermatitis. CZ patent utility model CZ37930U1. 2024 Jun 4."},{"key":"e_1_3_4_102_1","unstructured":"Turner P Chan B Wertz JE. Inventors; Yale University assignee. Bacteriophage compositions and uses thereof. WO patent WO2017189518A1. 2017 Nov 2."},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad051"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1694905"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002119"},{"key":"e_1_3_4_106_1","unstructured":"Luan G Qu Q He P et al. Inventors; Chengdu Xinyanji biotechnology Co Ltd assignee. Multiple drug-resistant enterococcus faecium phage and application thereof. CN patent CN116574692A. 2023 Aug 11."},{"key":"e_1_3_4_107_1","unstructured":"Yong D. inventor; Yonsei University industry-Academic cooperation Foundation assignee. Podoviridae bacteriophage having killing activity specific to gram-negative bacteria. KR patent KR101725570B1. 2017 Apr 11."},{"key":"e_1_3_4_108_1","unstructured":"Yong D Jeon J. Inventors; Yonsei University industry-Academic cooperation Foundation assignee. Lytic bacteriophage specific for Pseudomonas genus resistant to antibiotics. KR patent KR101789877B1. 2017 Oct 26."},{"key":"e_1_3_4_109_1","unstructured":"Yong D Jeon J. Inventors; Yonsei University industry-Academic cooperation Foundation assignee. Lytic bacteriophage specific for Pseudomonas genus resistant to antibiotics. KR patent KR101824778B1. 2018 Feb 1."},{"key":"e_1_3_4_110_1","unstructured":"Decrulle L Fernandez-Rodriguez J Duportet X et al. Inventors; Institut Pasteur assignee. Vectors optimized for delivery of microbial populations. JP patent JP7250702B2. 2023 Apr 3."},{"key":"e_1_3_4_111_1","unstructured":"Turner P Burmeister A Chan B et al. Inventors; Yale University assignee.Bacteriophage compositions and uses thereof. CA patent CA3139520A1. 2020 Nov 12."},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00801-12"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-76"},{"key":"e_1_3_4_114_1","unstructured":"Paros M Honaker R Hobbs ZA et al. Inventors; locus biosciences Inc assignee. Bacteriophage compositions and methods of use thereof. US patent US11311582B2. 2022 Apr 26."},{"key":"e_1_3_4_115_1","unstructured":"Pasternack G Sulakvelidze A. Inventors; Intralytix Inc assignee. Novel Staphylococcus aureus bacteriophage and uses thereof. WO patent WO2010033546A1. 2010 Mar 25."},{"key":"e_1_3_4_116_1","unstructured":"Thaller MC D\u2019Andrea MM Rossolini GM. Inventors; University of Siena assignee.Bacteriophage capable of lysing Klebsiella pneumoniae expressing a CPSKKBO-4 capsular polysaccharide and related medical uses. It patent ITUB20155372A1. 2017 May 9."},{"key":"e_1_3_4_117_1","unstructured":"Mimee M Rotman E. Inventors; the University of Chicago assignee. Bacteriophage compositions and methods for treatment of bacterial infections. WO patent WO 2024\/030896 A2. 2024 Feb 8."},{"key":"e_1_3_4_118_1","unstructured":"Deng L Khan Mirzaei M Xue J. Inventors; Helmholtz Zentrum M\u00fcnchen assignee.Acinetobacter baumannii phages. WO patent WO 2024\/115430 A1. 2024 Jun 6."},{"key":"e_1_3_4_119_1","unstructured":"Wu B Wang S Peng Z et al. Inventors; Huazhong agricultural University assignee. Mutant Staphylococcus aureus bacteriophage and application thereof. CN patent CN 114231500 B. 2023 Sep 12."},{"key":"e_1_3_4_120_1","unstructured":"Gong Y Yuan Z Le S et al. Inventors; first affiliated hospital of army medical University assignee. Carbapenem and polymyxin B drug-resistant Klebsiella pneumoniae lytic phage and application thereof. CN patent CN 118497138 a. 2024 Aug 16."},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.613356"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy947"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68702-y"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01832-20"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106199"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.13.47"},{"key":"e_1_3_4_127_1","unstructured":"Morales S Peermans G Rankin D et al. inventors; Armata Pharmaceuticals Inc. assignee. Therapeutic bacteriophage composition for treating staphylococcus infections. JP patent JP2021508740A. 2021 Mar 11."},{"key":"e_1_3_4_128_1","unstructured":"Weinstock E Weinerman IN Kahan-Hanum M et al. Inventors; Biomx Ltd. assignee. Klebsiella bacteriophage and uses thereof. WO patent WO2022157776A1. 2022 Jul 28."},{"key":"e_1_3_4_129_1","unstructured":"Zerbush LM Edgar R Sherman I et al. Inventors; Byomax Ltd assignee. Pseudomonas phage and application thereof. CN patent CN118103051A. 2024 May 28."},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2019.197734"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_2271_18"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02877-15"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac453"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1902754"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.05.022"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1111\/1462-2920.14310"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00954-17"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0311-5"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.11.017"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3564"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2020.04.010"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.4315\/0362-028X-63.8.1049"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3516-8_10"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34849"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.01.021"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2000.0110"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01209"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16030443"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2021.11.005"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1250848"},{"key":"e_1_3_4_151_1","unstructured":"Bacteriophage.news. STAMP protocol approved for phage therapy in Australia [Internet]. 2022 [cited 2025 May 22]. Available from: https:\/\/www.bacteriophage.news\/stamp-protocol-phage-therapy-in-australia\/"},{"key":"e_1_3_4_152_1","unstructured":"Infarmed \u2013 Portuguese Republic. DECISION NO.\u202f112\/CD\/2024 [Internet]. 2024 [cited 2025 May 22]. Available from: https:\/\/www.infarmed.pt\/documents\/15786\/9697484\/2024-11-15_Delibera%C3%A7%C3%A3o_112_CD_2024\/d0424242-a103-1256-cd7d-526aaf12dfac"},{"key":"e_1_3_4_153_1","unstructured":"Committees - UK parliament. The antimicrobial potential of bacteriophages [Internet]. [cited 2025 May 22]. Available from: https:\/\/committees.parliament.uk\/work\/7045\/the-antimicrobial-potential-of-bacteriophages\/"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2025.2545784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T11:13:56Z","timestamp":1756725236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2025.2545784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":152,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/13543776.2025.2545784"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2025.2545784","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}